[
  {
    "ts": null,
    "headline": "J&J's MedTech Segment Slowing Down: Will its Sales Recover in 2025?",
    "summary": "JNJ's MedTech sales face pressure from China and competition but new products may lead to a stronger second half of 2025.",
    "url": "https://finnhub.io/api/news?id=9d6e05244b83880cade9cee8551356a10de2bfee1ac0ef7019ebf8205321e6f9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750945200,
      "headline": "J&J's MedTech Segment Slowing Down: Will its Sales Recover in 2025?",
      "id": 135560164,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "JNJ's MedTech sales face pressure from China and competition but new products may lead to a stronger second half of 2025.",
      "url": "https://finnhub.io/api/news?id=9d6e05244b83880cade9cee8551356a10de2bfee1ac0ef7019ebf8205321e6f9"
    }
  },
  {
    "ts": null,
    "headline": "Want Decades of Passive Income? 5 Stocks to Buy Now and Hold Forever",
    "summary": "Forever is a tricky word in the stock market, but these stocks are as safe as they come and will pay you to hold them.",
    "url": "https://finnhub.io/api/news?id=3f5b4eff20c4bf2b454db5c6155968888aae19f2fbbc24b107cb648b5d72082c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750941900,
      "headline": "Want Decades of Passive Income? 5 Stocks to Buy Now and Hold Forever",
      "id": 135558720,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Forever is a tricky word in the stock market, but these stocks are as safe as they come and will pay you to hold them.",
      "url": "https://finnhub.io/api/news?id=3f5b4eff20c4bf2b454db5c6155968888aae19f2fbbc24b107cb648b5d72082c"
    }
  },
  {
    "ts": null,
    "headline": "Retinitis Pigmentosa Research Report 2025: $25+ Bn Market Opportunities and Strategies to 2034 - Gene Therapy Poised as Fastest Growing Treatment Segment, Strategic Collaborations Drive Advancements",
    "summary": "The global retinitis pigmentosa market, valued at $11.31 billion in 2024, is expected to grow to $25.87 billion by 2034, driven by gene therapy advancements, aging populations, and strategic industry collaborations. North America leads, while Asia-Pacific demonstrates rapid growth. Key players include Johnson & Johnson and Novartis AG. Retinitis Pigmentosa Market Retinitis Pigmentosa Market Dublin, June 26, 2025 (GLOBE NEWSWIRE) -- The \"Retinitis Pigmentosa Market Opportunities and Strategies to",
    "url": "https://finnhub.io/api/news?id=86a6d36ed42118e9a8d65a072ff9f7dc2d85983be43a91072de6fdb07110e5fd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750932720,
      "headline": "Retinitis Pigmentosa Research Report 2025: $25+ Bn Market Opportunities and Strategies to 2034 - Gene Therapy Poised as Fastest Growing Treatment Segment, Strategic Collaborations Drive Advancements",
      "id": 135553110,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The global retinitis pigmentosa market, valued at $11.31 billion in 2024, is expected to grow to $25.87 billion by 2034, driven by gene therapy advancements, aging populations, and strategic industry collaborations. North America leads, while Asia-Pacific demonstrates rapid growth. Key players include Johnson & Johnson and Novartis AG. Retinitis Pigmentosa Market Retinitis Pigmentosa Market Dublin, June 26, 2025 (GLOBE NEWSWIRE) -- The \"Retinitis Pigmentosa Market Opportunities and Strategies to",
      "url": "https://finnhub.io/api/news?id=86a6d36ed42118e9a8d65a072ff9f7dc2d85983be43a91072de6fdb07110e5fd"
    }
  },
  {
    "ts": null,
    "headline": "J&J teams with Nvidia, Amazon on fund for AI surgery solutions",
    "summary": "J&J is offering up to $100,000 in grant funding, mentorship and access to computing capabilities.",
    "url": "https://finnhub.io/api/news?id=80751fe5dfc88920cefedb05cdb86ffbfe8ebc47f24862054c6e218a3a9efaa4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750932000,
      "headline": "J&J teams with Nvidia, Amazon on fund for AI surgery solutions",
      "id": 135559317,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "J&J is offering up to $100,000 in grant funding, mentorship and access to computing capabilities.",
      "url": "https://finnhub.io/api/news?id=80751fe5dfc88920cefedb05cdb86ffbfe8ebc47f24862054c6e218a3a9efaa4"
    }
  },
  {
    "ts": null,
    "headline": "How Earle Dickson Healed Wound Care With The Band-Aid",
    "summary": "How Earle Dickson Healed Wound Care With The Band-Aid",
    "url": "https://finnhub.io/api/news?id=930f0ed827ebcd4d9ee5fb73e07365693a796a7889a8f0890252f25f028990df",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750921211,
      "headline": "How Earle Dickson Healed Wound Care With The Band-Aid",
      "id": 135562040,
      "image": "",
      "related": "JNJ",
      "source": "DowJones",
      "summary": "How Earle Dickson Healed Wound Care With The Band-Aid",
      "url": "https://finnhub.io/api/news?id=930f0ed827ebcd4d9ee5fb73e07365693a796a7889a8f0890252f25f028990df"
    }
  }
]